Janney Montgomery Scott LLC purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 9,604 shares of the company's stock, valued at approximately $372,000.
A number of other institutional investors and hedge funds also recently modified their holdings of BBWI. Creative Planning increased its stake in Bath & Body Works by 8.1% during the 2nd quarter. Creative Planning now owns 16,648 shares of the company's stock worth $650,000 after purchasing an additional 1,254 shares in the last quarter. GAMMA Investing LLC increased its stake in Bath & Body Works by 34.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company's stock worth $79,000 after purchasing an additional 635 shares in the last quarter. CWM LLC increased its stake in Bath & Body Works by 255.3% during the 3rd quarter. CWM LLC now owns 18,022 shares of the company's stock worth $575,000 after purchasing an additional 12,950 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock worth $38,000 after purchasing an additional 900 shares in the last quarter. Finally, Vontobel Holding Ltd. increased its stake in Bath & Body Works by 24.5% during the 3rd quarter. Vontobel Holding Ltd. now owns 6,494 shares of the company's stock worth $207,000 after purchasing an additional 1,279 shares in the last quarter. 95.14% of the stock is owned by institutional investors.
Bath & Body Works Price Performance
Bath & Body Works stock traded up $0.07 during mid-day trading on Friday, hitting $36.50. 1,835,171 shares of the company's stock traded hands, compared to its average volume of 3,008,922. The firm has a 50 day simple moving average of $37.63 and a two-hundred day simple moving average of $33.70. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock has a market cap of $7.91 billion, a price-to-earnings ratio of 8.90, a P/E/G ratio of 0.90 and a beta of 1.83.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the firm posted $0.48 EPS. The company's quarterly revenue was up 3.1% on a year-over-year basis. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works's dividend payout ratio is currently 19.51%.
Wall Street Analyst Weigh In
BBWI has been the subject of several research reports. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a research note on Thursday, November 21st. Deutsche Bank Aktiengesellschaft raised their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, TD Cowen raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, December 12th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus target price of $43.19.
View Our Latest Stock Analysis on Bath & Body Works
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
